Related Experiment Video
Updated: Feb 14, 2026
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Understanding novel mechanisms of microbial pathogenesis in chronic lung disease: implications for new therapeutic
Mathew Suji Eapen1, Sukhwinder Singh Sohal2
1Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania, Australia.
Abstract:
Airway infections are considered as one of the vital factors driving the pathophysiology of chronic lung disease with significant influences on disease trajectory. Opportunistic lung microbes in diseased conditions induce excessive exacerbations and contribute to airflow limitation. Though there has been considerable amount of information that ascertains their links with airway inflammation, the intricate interaction in clinical conditions are poorly understood and requires further deciphering. Current therapeutic interventions for such pathologies are few and lack the ability to modulate underlying dysfunctional immunity as well as suppress the excessive infectious conditions. Thus, in this Commentary we provide a focused outlook on the mechanisms involved in microbial infestation in lung diseases and provides important information on new therapeutic interventions including the potential role of Resolvins and their derivatives as alternative therapeutic agents in combating such multifaceted pathological mechanisms.
Insights
Airway infections worsen chronic lung disease by triggering inflammation and exacerbations. New therapies, like Resolvins, show promise in managing these microbial-driven lung pathologies and dysfunctional immunity.
Area of Science:
- Pulmonology and Infectious Diseases
- Immunology
- Pharmacology
Background:
- Airway infections are key drivers in chronic lung disease pathophysiology.
- Opportunistic lung microbes exacerbate disease and limit airflow.
- The complex interactions between microbes and lung disease are not fully understood.
Purpose of the Study:
- To explore mechanisms of microbial infestation in lung diseases.
- To discuss novel therapeutic interventions.
- To highlight the potential of Resolvins in treating these conditions.
Main Methods:
- Review of existing literature on microbial lung disease interactions.
- Analysis of current therapeutic limitations.
- Exploration of emerging therapeutic strategies.
Main Results:
- Microbial infections significantly impact chronic lung disease progression.
- Existing treatments are insufficient to address immune dysfunction and infection.
- Resolvins and derivatives offer a potential new therapeutic avenue.
Conclusions:
- Understanding microbial mechanisms is crucial for chronic lung disease management.
- Novel treatments targeting immunity and infection are needed.
- Resolvins represent a promising alternative for multifaceted lung pathologies.
More Related Videos
06:56Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
Published on: September 26, 2012
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Chronic Kidney Disease I: Introduction
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:24Chronic Kidney Disease II: Clinical Manifestations
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation